TY - JOUR
T1 - Natural history, angiographic presentation and outcomes of anterior cranial fossa dural arteriovenous fistulas
AU - Sanchez, Sebastian
AU - Raghuram, Ashrita
AU - Wendt, Linder
AU - Hayakawa, Minako
AU - Chen, Ching Jen
AU - Sheehan, Jason P.
AU - Kim, Louis J.
AU - Abecassis, Isaac Josh
AU - Levitt, Michael R.
AU - Meyer, R. Michael
AU - Guniganti, Ridhima
AU - Kansagra, Akash P.
AU - Lanzino, Giuseppe
AU - Giordan, Enrico
AU - Brinjikji, Waleed
AU - Bulters, Diederik O.
AU - Durnford, Andrew
AU - Fox, W. Christopher
AU - Smith, Jessica
AU - Polifka, Adam J.
AU - Gross, Bradley
AU - Amin-Hanjani, Sepideh
AU - Alaraj, Ali
AU - Kwasnicki, Amanda
AU - Starke, Robert M.
AU - Chen, Stephanie H.
AU - Van Dijk, J. Marc C.
AU - Potgieser, Adriaan R.E.
AU - Satomi, Junichiro
AU - Tada, Yoshiteru
AU - Phelps, Ryan
AU - Abla, Adib
AU - Winkler, Ethan
AU - Du, Rose
AU - Lai, Pui Man Rosalind
AU - Zipfel, Gregory J.
AU - Derdeyn, Colin
AU - Samaniego, Edgar A.
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2023/9/1
Y1 - 2023/9/1
N2 - Background Anterior cranial fossa dural arteriovenous fistulas (ACF-dAVFs) are aggressive vascular lesions. The pattern of venous drainage is the most important determinant of symptoms. Due to the absence of a venous sinus in the anterior cranial fossa, most ACF-dAVFs have some degree of drainage through small cortical veins. We describe the natural history, angiographic presentation and outcomes of the largest cohort of ACF-dAVFs. Methods The CONDOR consortium includes data from 12 international centers. Patients included in the study were diagnosed with an arteriovenous fistula between 1990-2017. ACF-dAVFs were selected from a cohort of 1077 arteriovenous fistulas. The presentation, angioarchitecture and treatment outcomes of ACF-dAVF were extracted and analyzed. Results 60 ACF-dAVFs were included in the analysis. Most ACF-dAVFs were symptomatic (38/60, 63%). The most common symptomatic presentation was intracranial hemorrhage (22/38, 57%). Most ACF-dAVFs drained through cortical veins (85%, 51/60), which in most instances drained into the superior sagittal sinus (63%, 32/51). The presence of cortical venous drainage predicted symptomatic presentation (OR 9.4, CI 1.98 to 69.1, p=0.01). Microsurgery was the most effective modality of treatment. 56% (19/34) of symptomatic patients who were treated had complete resolution of symptoms. Improvement of symptoms was not observed in untreated symptomatic ACF-dAVFs. Conclusion Most ACF-dAVFs have a symptomatic presentation. Drainage through cortical veins is a key angiographic feature of ACF-dAVFs that accounts for their malignant course. Microsurgery is the most effective treatment. Due to the high risk of bleeding, closure of ACF-dAVFs is indicated regardless of presentation.
AB - Background Anterior cranial fossa dural arteriovenous fistulas (ACF-dAVFs) are aggressive vascular lesions. The pattern of venous drainage is the most important determinant of symptoms. Due to the absence of a venous sinus in the anterior cranial fossa, most ACF-dAVFs have some degree of drainage through small cortical veins. We describe the natural history, angiographic presentation and outcomes of the largest cohort of ACF-dAVFs. Methods The CONDOR consortium includes data from 12 international centers. Patients included in the study were diagnosed with an arteriovenous fistula between 1990-2017. ACF-dAVFs were selected from a cohort of 1077 arteriovenous fistulas. The presentation, angioarchitecture and treatment outcomes of ACF-dAVF were extracted and analyzed. Results 60 ACF-dAVFs were included in the analysis. Most ACF-dAVFs were symptomatic (38/60, 63%). The most common symptomatic presentation was intracranial hemorrhage (22/38, 57%). Most ACF-dAVFs drained through cortical veins (85%, 51/60), which in most instances drained into the superior sagittal sinus (63%, 32/51). The presence of cortical venous drainage predicted symptomatic presentation (OR 9.4, CI 1.98 to 69.1, p=0.01). Microsurgery was the most effective modality of treatment. 56% (19/34) of symptomatic patients who were treated had complete resolution of symptoms. Improvement of symptoms was not observed in untreated symptomatic ACF-dAVFs. Conclusion Most ACF-dAVFs have a symptomatic presentation. Drainage through cortical veins is a key angiographic feature of ACF-dAVFs that accounts for their malignant course. Microsurgery is the most effective treatment. Due to the high risk of bleeding, closure of ACF-dAVFs is indicated regardless of presentation.
KW - Fistula
KW - Hemorrhage
KW - Intervention
UR - http://www.scopus.com/inward/record.url?scp=85136488535&partnerID=8YFLogxK
U2 - 10.1136/jnis-2022-019160
DO - 10.1136/jnis-2022-019160
M3 - Article
C2 - 35944975
AN - SCOPUS:85136488535
SN - 1759-8478
VL - 15
SP - 903
EP - 908
JO - Journal of NeuroInterventional Surgery
JF - Journal of NeuroInterventional Surgery
IS - 9
ER -